✦ LIBER ✦

Use of Montelukast in tapering inhaled corticosteroid therapy: an open-label, 48-week trial

✍ Scribed by David B Price; Michel Y Rouleau; Christopher P Fletcher; Piyush Patel; Ronald Olivenstein; Leiv Myhr; J.Christian Virchow Jr; W.R Cameron Aitchison; Ernst R Omenaas; Pam S Dellea; Martino Laurenzi; Jonathan A Leff

Book ID: 117090209
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 709 KB
Volume: 62
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(01)80081-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of clopidogrel with or without aspir

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

✍ Dewilde, Willem JM; Oirbans, Tom; Verheugt, Freek WA; Kelder, Johannes C; De Sme 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 294 KB

Dual therapy with lopinavir and ritonavi

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

✍ Cahn, Pedro; Andrade-Villanueva, Jaime; Arribas, José R; Gatell, José M; Lama, J 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 321 KB

Durable efficacy of tipranavir-ritonavir

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

✍ Charles B Hicks; Pedro Cahn; David A Cooper; Sharon L Walmsley; Christine Katlam 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 124 KB